Drug Type Small molecule drug |
Synonyms Compound 14f |
Target |
Mechanism CMKLR1 antagonists(Chemokine like receptor 1 antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Autoimmune Diseases | Preclinical | JP | 12 Mar 2022 |